S310: VENETOCLAX PLUS AZACITIDINE DELAYS DETERIORATION OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: VIALE-A LONG-TERM FOLLOW UP
Keith Pratz,
Catherine Lai,
Brian A. Jonas,
Courtney Dinardo,
Cat N. Bui,
Rajesh Kamalakar,
Jalaja Potluri,
Wei-Han Chang,
Rohini Sen,
Thomas W Leblanc
Affiliations
Keith Pratz
1 University of Pennsylvania, Abramson Cancer Center, Philadelphia, United States
Catherine Lai
1 University of Pennsylvania, Abramson Cancer Center, Philadelphia, United States
Brian A. Jonas
2 University of California Davis School of Medicine, Department of Internal Medicine, Division of Malignant Hematology, Cellular Therapy and Transplantation, Sacramento, United States
Courtney Dinardo
3 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine, Houston, United States
Cat N. Bui
4 AbbVie Inc., North Chicago, United States
Rajesh Kamalakar
4 AbbVie Inc., North Chicago, United States
Jalaja Potluri
4 AbbVie Inc., North Chicago, United States
Wei-Han Chang
4 AbbVie Inc., North Chicago, United States
Rohini Sen
4 AbbVie Inc., North Chicago, United States
Thomas W Leblanc
5 Duke University School of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Durham, United States
